Search
Search Results
-
Management of Chronic Kidney Disease A Clinician’s Guide
The second edition of this essential work presents how to diagnose, treat and develop an appropriate management plan for patients with chronic kidney...
-
Pediatric Kidney Disease
The extensively revised third edition of this text offers an in-depth practical guide to clinical conditions encountered in pediatric nephrology....
-
Approaches to Chronic Kidney Disease A Guide for Primary Care Providers and Non-Nephrologists
Chronic kidney disease (CKD) is a major global public health problem, affecting nearly one in seven adults in the United States alone. It is a...
-
Sleep disorders in chronic kidney disease
Sleep disorders are highly prevalent in chronic kidney disease (CKD) but are often under-recognized. Restless legs syndrome, which is common in CKD...
-
Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease
Chronic kidney disease (CKD) is a global health problem with rising incidence and prevalence. Among several pathogenetic mechanisms responsible for...
-
Smoking status, cadmium, and chronic kidney disease
BackgroundChronic kidney disease (CKD) affects 10% of the general population in Western countries. Currently, CKD cannot be cured and there are only...
-
Diagnosis of cardiovascular disease in patients with chronic kidney disease
Patients with chronic kidney disease (CKD) are at high risk of cardiovascular disease (CVD) and cardiovascular death. Identifying and monitoring...
-
Galectin-3: action and clinical utility in chronic kidney disease
Chronic kidney disease is a significant cause of morbidity and mortality worldwide. In recent years, Galectin-3 has been put forward as a potential...
-
Uremic toxins and the brain in chronic kidney disease
Chronic kidney disease (CKD) patients have an increased risk for cognitive impairment compared to the general population. The risk is much higher in...
-
Monogenic and polygenic concepts in chronic kidney disease (CKD)
Kidney function is strongly influenced by genetic factors with both monogenic and polygenic factors contributing to kidney function. Monogenic...
-
Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease
BackgroundIn this study, we aimed to clarify the beneficial effects of urate-lowering treatment with the novel agent dotinurad on renal function in...
-
Increased cardiovascular risk in patients with chronic kidney disease
Cardiovascular disease (CVD) is highly prevalent in patients suffering from chronic kidney disease (CKD). The risk of patients with CKD develo**...
-
Chronic kidney disease and its association with cerebral small vessel disease in the general older hypertensive population
BackgroundCerebral small vessel disease can be identified using magnetic resonance imaging, and includes white matter hyperintensities, lacunar...
-
Kidney supportive care for advanced chronic and end-stage kidney disease: a retrospective cohort study
BackgroundKidney supportive care is an interdisciplinary model of person-centred medicine, suitable for patients with advanced Chronic Kidney Disease...
-
Prime time for chronic kidney disease
Chronic kidney disease (CKD) represents a public health burden worldwide and is associated with significant morbidity and mortality. Most patients...
-
The multifaceted links between hearing loss and chronic kidney disease
Hearing loss affects nearly 1.6 billion people and is the third-leading cause of disability worldwide. Chronic kidney disease (CKD) is also a common...
-
Hypertension and Cardiovascular Risk Among Children with Chronic Kidney Disease
Purpose of ReviewCardiovascular disease is the most common cause of mortality across the lifespan of children with chronic kidney disease (CKD)....
-
Real world evaluation of kidney failure risk equations in predicting progression from chronic kidney disease to kidney failure in an Australian cohort
BackgroundChronic kidney disease progression to kidney failure is diverse, and progression may be different according to genetic aspects and settings...
-
Pulmonary hypertension and chronic kidney disease: prevalence, pathophysiology and outcomes
Pulmonary hypertension (PH) is common in patients with chronic kidney disease (CKD) or kidney failure, with an estimated prevalence of up to 78% in...
-
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA–KIDNEY
BackgroundEMPA–KIDNEY assessed the effects of empagliflozin 10 mg once daily vs. placebo in 6609 patients with chronic kidney disease (CKD) at risk...
